Topical Corticosteroids Market Report 2025

The topical corticosteroids market size has grown strongly in recent years. It will grow from $8.51 billion in 2024 to $9.17 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historical period is driven by the rising prevalence of skin disorders, increased demand for safer and more effective dermatological treatments, improvements in drug delivery technologies, heightened awareness of skin health, and expanded use of formulations for pediatric and sensitive skin.

The topical corticosteroids market size is expected to see strong growth in the next few years. It will grow to $12.24 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The expected growth during the forecast period is driven by a rising incidence of skin disorders, increased use of topical corticosteroids in combination therapies, innovations in formulation technologies for targeted delivery, growing awareness of steroid-sparing treatment options, and favorable regulatory approvals. Key trends include the treatment of dermatitis across various age groups, a focus on low-potency formulations, integration into combination creams, advancements in delivery systems, and the development of steroid-sparing alternatives.

The increasing occurrence of skin disorders is expected to drive the growth of the topical corticosteroids market in the future. Skin disorders encompass a variety of conditions that affect the skin’s appearance, structure, or function, potentially impacting overall health, comfort, and quality of life. This rise in skin disorders is linked to stressful modern lifestyles marked by long work hours, poor nutrition, and extended screen time, all of which negatively affect skin health and prompt people to seek effective skincare and dermatological treatments. Topical corticosteroids play a crucial role in managing skin disorders by reducing inflammation, itching, and redness through the suppression of overactive immune responses, making them essential for treating conditions such as eczema, psoriasis, and dermatitis. For example, in April 2022, the American Journal of Managed Care, a US-based peer-reviewed publication, reported that 43% of 40,000 patients experienced at least one skin condition or issue in the past year. Hence, the growing prevalence of skin disorders is fueling the expansion of the topical corticosteroids market.

Leading companies in the topical corticosteroids market are emphasizing innovative products like oil-in-water emulsion formulations to enhance drug stability, patient compliance, and treatment effectiveness. This oil-in-water emulsion allows for the stable combination of traditionally incompatible active ingredients into a single, effective aqueous cream base, improving both skin absorption and therapeutic impact. For instance, in May 2022, Almirall, a Spain-based dermatology-focused pharmaceutical company, introduced Wynzora Cream, a novel topical treatment combining calcipotriol and betamethasone dipropionate - a Class III potent corticosteroid - in an innovative aqueous cream formula. Wynzora provides effective once-daily therapy for mild to moderate plaque psoriasis, offering high efficacy, better patient adherence, and suitability for use on both the body and scalp.

In June 2025, Harrow, a US-based ophthalmic pharmaceutical company, acquired the exclusive U.S. commercial rights to BYQLOVI (clobetasol propionate ophthalmic suspension) 0.05% from Formosa Pharmaceuticals for an undisclosed amount. Following this acquisition, Formosa will continue to operate independently, while Harrow will handle the commercialization of BYQLOVI, a topical corticosteroid, in the U.S. market, ensuring ongoing product availability and brand presence. Formosa Pharmaceuticals is a Taiwan-based biopharmaceutical firm specializing in developing innovative ophthalmic topical corticosteroids and oncology drug formulations.

Major players in the topical corticosteroids market are Merck & Co. Inc., GSK plc, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Macleods Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Menarini Group, Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, LEO Pharma A/S, Taro Pharmaceutical Industries Ltd., Ajanta Pharma Ltd., Micro Labs Ltd., FDC Limited, Harrow Inc., Salve Pharmaceuticals Pvt. Ltd., Lincoln Pharmaceuticals Ltd., and Emcure Pharmaceuticals Ltd.

North America was the largest region in the topical corticosteroids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the Topical Corticosteroids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The topical corticosteroids market consists of sales of creams, ointments, lotions, gels, and foams. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The topical corticosteroids market research report is one of a series of new reports that provides topical corticosteroids market statistics, including topical corticosteroids industry global market size, regional shares, competitors with a topical corticosteroids market share, topical corticosteroids market segments, market trends and opportunities, and any further data you may need to thrive in the topical corticosteroids industry. This topical corticosteroids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Topical corticosteroids are medications applied directly to the skin to alleviate inflammation, redness, and itching by replicating the effects of adrenal gland hormones. They function by suppressing the immune response in the treated area, making them effective for managing various skin conditions like eczema, psoriasis, and dermatitis.

The primary categories of topical corticosteroids include prescription and over-the-counter (OTC) products. A prescription is an authorization from a licensed healthcare professional allowing patients to obtain medications that are not available without medical approval. These medications come in various forms such as ointments, creams, liquids, lotions, gels, oils, pastes, sprays, and more. They are distributed through channels including hospital pharmacies, retail pharmacy stores, online pharmacies, and others. Topical corticosteroids are used for a range of conditions including acne, dermatitis, psoriasis, skin infections, hyperpigmentation, and melasma, and serve end users such as hospitals, dermatology clinics, homecare providers, and others.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.